FULCRUM THERAPEUTICS, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2022 | — | $189.2M | $33.3M |
| Jun 2022 | — | $160.8M | $40.2M |
| Sep 2022 | — | $221.4M | $90.9M |
| Dec 2022 | — | $198.9M | $35.1M |
| Mar 2023 | — | $296.3M | $34.7M |
| Jun 2023 | — | $275.4M | $34.0M |
| Sep 2023 | — | $255.5M | $30.1M |
| Dec 2023 | — | $235.2M | $25.6M |
| Mar 2024 | — | $213.6M | $39.9M |
| Jun 2024 | — | $273.8M | $86.7M |
| Sep 2024 | — | $257.3M | $72.6M |
| Dec 2024 | — | $243.0M | $58.2M |
| Mar 2025 | — | $228.5M | $42.2M |
| Jun 2025 | — | $214.4M | $42.6M |
| Sep 2025 | — | $198.4M | $47.1M |
| Dec 2025 | — | $349.0M | $197.5M |
| Mar 2026 | — | $333.3M | $50.3M |
| Jun 2026 | — | $310.7M | $48.5M |